Fielmann Group shares closed at €39.10 after a choppy stretch that left the stock down about 12.5% over three months. The market has been fixated on the guidance cut and softer recent trading. The headline from these Q2 numbers is different. The company kept its adjusted profitability broadly intact on a record profit base while trailing twelve month earnings reached €2.48 per share. For a retailer that relies on steady optical demand, the story now turns less on this quarter’s wobble and more on whether today’s valuation still reflects that earnings power.
Love that Fielmann Group kept adjusted profitability steady on a record profit base but uneasy about near term guidance and trading softness? Take a look at the 309 resilient stocks with low risk scores for other stocks aiming to pair resilient earnings profiles with lower perceived downside.
Q2 2026 Earnings Summary
- Revenue (Q2 2026 vs Q2 2025): €634.897m vs. €622.919m (up about 1.9%)
- Net Income (Excl. Extra Items, Q2 2026 vs Q2 2025): €55.813m vs. €51.682m (up about 8.0%)
- Basic EPS (Q2 2026 vs Q2 2025): €0.67 vs. €0.62 (up about 8.1%)
- Trailing Twelve Month Basic EPS (Q2 2026 vs Q2 2025): €2.48 vs. €2.04 (up about 21.6%)
Tired of reading through extensive earnings tables and raw figures for Fielmann Group? See the full picture of the company, including a clear view on valuation and supporting charts, in the company report for Fielmann Group.
Fielmann bull case hinges on earnings resilience
Bulls argue Fielmann can convert modest top line progress into much stronger earnings through vertical integration and cost discipline. The Q2 and H1 2026 print gives that claim some support. Revenue is moving only slowly, with H1 growth of 2.3% at constant currency and 1.8% reported, yet adjusted EBITDA stayed roughly flat on what management calls a record profit baseline. The H1 margin held around 24%. Trailing twelve month EPS of €2.48 versus €2.04 a year earlier backs the idea that earnings power is building even without rapid sales growth. International markets and audiology show healthier trends than Germany, which fits the diversification angle. However, the guidance cut to an adjusted EBITDA margin of 22% to 23% for 2026 signals that operating leverage is not yet a one way street.
Bear case focuses on guidance cut and Germany drag
Bears worry that weak German demand, slower spending by consumers and execution risk in the U.S. will cap Fielmann’s earnings progress. The recent guidance cut is clear ammunition for that view. Management now sees 2026 revenue at €2.5b to €2.55b with adjusted EBITDA of €560m to €580m. This implies a margin step down from the approximately 24% seen in H1. German growth was around 1% in H1 and flat in Q2, which underlines concerns about the largest market. There is also a short term margin drag from building U.S. doctor capacity and expanding the store base. At the same time, management stresses that gross margins and adjusted EBT margin are stable and that July and August trends improved, which pushes back on fears of a deeper structural break in the model.
Compare Fielmann Group’s record profit base and margin guidance with how the market is now pricing the stock after the August earnings release. Then see whether analysts think the story still adds up through the consensus price target analysis for Fielmann Group.Take Control Of Your Next Move
If the mix of record profit, guidance cut and Germany softness has put Fielmann Group on your radar, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how the thesis develops. Once you own or plan to own the stock, use the Portfolio Command Center to keep your holdings organised and get only the key updates that matter for your decisions. For a broader view on what other investors are thinking, tap into the Community and compare different angles on the same numbers. That way you can spot potential catalysts or emerging risks early and stay one step ahead of the market.
Seeking Alternatives Beyond Fielmann Group?
The next breakout ideas often start flying before most investors notice. Use these fresh stock lists while they remain under the radar for now and get in early.
- Ride potential momentum in cash generative compounders by scanning a curated 266 high quality undervalued stocks that could be slipping past investors focused only on headline growth stories.
- Spot companies quietly building strong balance sheets before the crowd catches on by reviewing a hand picked list of solid balance sheet and fundamentals stocks (427 results) that filters out fragile business models.
- Target structural themes in automation and productivity gains by checking a focused 37 robotics and automation stocks that highlights businesses aiming to turn long term robotics trends into earnings power.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com